Following on from previous successes, I had the opportunity to follow an entrepreneurial dream and co-founded a small pharmaceutical company, Nascent Pharmaceuticals. It has been a great experience, often fun, sometimes frustrating, but always educational. The company, however, is currently in a state of transition as it divests and partners its two key assets. For whatever lies ahead, whether with another small start-up opportunity or possibly in venture capital, it is clear that as a scientist, I need greater breadth and depth in my business education.
A colleague and I came up with the original concept for Nascent ten years ago. The name Nascent, appropriately, means emerging or coming into existence. The company was to opportunistically acquire rights to a portfolio of emerging pharmaceutical products, take them through the early stages of development and then out-license them to larger pharmaceutical companies in need of pipeline products. Two CEO’s and five years later, out of money and looking to divest the assets, I look back and reflect on what could have been done differently. After being turned down by dozens of venture capitalists and pharmaceutical companies, the skin is thicker and the brow more wizened. My operations experience comes from more than twenty years with several very successful entrepreneurial companies, having been through an IPO, numerous financings, an acquisition and commercialization of several products.
I have wanted to pursue an MBA for many years. Several times during my career I have taken business courses with that in mind, but each time, a combination of job changes, business commitments and having a young family have put that pursuit on hold. With a wealth of experience behind me and my children grown, I now have the time and desire to complete this next phase of my education.
Wednesday, September 19, 2007
Subscribe to:
Comments (Atom)